New patent for Novartis drug SCEMBLIXBy DrugPatentWatch – Make Better Decisions / May 14, 2024 Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…Source